The U.S. Federal Trade Commission said on Friday it was suing the country's three largest pharmacy benefit managers, accusing them of abusing their power and rigging the pharmaceutical supply chain to ...
A group of Fortune 15 corporations have amassed enormous power as controversial middlemen between insurers, patients, drug ...
The 2024 Pharmacy Benefit Manager Customer Satisfaction Report published by Pharmaceutical Strategies Group ("PSG") disclosed ...
California Gov. Gavin Newsom will soon decide whether the most populous U.S. state will join 25 others in regulating the ...
Jazz Pharma's diversified drug portfolio drives revenue growth. Zanidatamab shows promise with potential FDA approval in late ...
Astellas Pharma announces US FDA listing of DIGITIVA for the management of heart failure: Tokyo Friday, September 20, 2024, 11:00 Hrs [IST] Astellas Pharma Inc. announced that DIG ...
Astellas Pharma Inc. (ALPMY, ALPMY) announced that DIGITIVA, a non-invasive digital health solution for heart failure management, has ...